Literature DB >> 5273757

Carcinostatic activity of thiosemicarbazones of formyl heteroaromatic compounds. VI. 1-Formylisoquinoline derivatives bearing additional ring substituents, with notes on mechanism of action.

F A French, E J Blanz, J R DoAmaral, D A French.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5273757     DOI: 10.1021/jm00300a024

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  5 in total

Review 1.  Antifungal and antitumor activity of heterocyclic thiosemicarbazones and their metal complexes: current status.

Authors:  A E Liberta; D X West
Journal:  Biometals       Date:  1992       Impact factor: 2.949

2.  Activity of 2-acetylpyridine thiosemicarbazones against Trypanosoma rhodesiense in vitro.

Authors:  R A Casero; D L Klayman; G E Childs; J P Scovill; R E Desjardins
Journal:  Antimicrob Agents Chemother       Date:  1980-08       Impact factor: 5.191

3.  Inhibition of RNA-dependent DNA polymerase of Rous sarcoma virus by thiosemicarbazones and several cations.

Authors:  W Levinson; A Faras; B Woodson; J Jackson; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1973-01       Impact factor: 11.205

4.  Isoquinoline thiosemicarbazone displays potent anticancer activity with in vivo efficacy against aggressive leukemias.

Authors:  Daniel L Sun; Soumya Poddar; Roy D Pan; Ethan W Rosser; Evan R Abt; Juno Van Valkenburgh; Thuc M Le; Vincent Lok; Selena P Hernandez; Janet Song; Joanna Li; Aneta Turlik; Xiaohong Chen; Chi-An Cheng; Wei Chen; Christine E Mona; Andreea D Stuparu; Laurent Vergnes; Karen Reue; Robert Damoiseaux; Jeffrey I Zink; Johannes Czernin; Timothy R Donahue; Kendall N Houk; Michael E Jung; Caius G Radu
Journal:  RSC Med Chem       Date:  2020-02-24

5.  Cytotoxic and Antitumour Studies of Acetoacetanilide N(4)-methyl(phenyl)thiosemicarbazone and its Transition Metal Complexes.

Authors:  N P Priya; A P Firdous; R Jeevana; K K Aravindakshan
Journal:  Indian J Pharm Sci       Date:  2015 Nov-Dec       Impact factor: 0.975

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.